Praecis Pharmaceuticals Inc
About Praecis Pharmaceuticals Inc
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies to address significant unmet medical needs. In the United States PRAECIS has received FDA approval to market Plenaxis® (abarelix for injectable suspension).
Two of their programs have moved beyond the research phase and into clinical testing:
Apan™ for Alzheimer's Disease
PPI-2458 for Non-Hodgkin's Lymphoma
In addition, Praecis has a number of research programs focused on developing therapies to treat rheumatoid arthritis, certain types of cancer, and other diseases.
PRODUCT PIPELINE
PPI-2458 for Non-Hodgkin's Lymphoma/ Arthritis